8-KThe WireRoutine
Shareholder Vote
Filed Jun 16, 2023 · 3y ago · Accession 0001193125-23-168977
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kymera Therapeutics, Inc.
- Ticker
- KYMR
- CIK
- 1815442
- Form type
- 8-K
- Filing date
- Jun 16, 2023
- Report date
- Jun 15, 2023
- Document
- d516155d8k.htm
- Size
- 154 KB